期刊文献+

ALT正常的慢性乙型肝炎抗病毒治疗策略 预览 被引量:1

Antiviral therapeutic strategies for chronic hepatitis B patients with a normal alanine aminotransferase level
在线阅读 下载PDF
收藏 分享 导出
摘要 ALT是临床上用于反映肝组织损伤最敏感的生化指标之一.通常认为ALT水平正常的HBV感染者处于免疫耐受状态,肝组织病理无或仅有轻度的炎症,则无需抗病毒治疗.然而ALT水平正常的慢性HBV感染者并非始终处于免疫耐受状态,疾病可隐匿进展为慢性乙型肝炎(CHB),甚至肝硬化、肝细胞癌.因此,ALT水平正常的CHB抗病毒治疗一直是临床研究的热点.主要从ALT与CHB肝组织炎症的关系和ALT水平正常的CHB抗病毒治疗时机等方面进行了阐述. Alanine aminotransferase (ALT) is one of the most sensitive biochemical parameters used to reflect the degree of liver injury.It is generally believed that patients with hepatitis B virus (HBV) infection and a normal ALT level are in the immune tolerance state,and no antiviral therapy is required in patients without liver inflammation or those with mild liver inflammation.However,these patients are not always in the immune tolerance state,and the disease can insidiously progress to chronic hepatitis B (CHB),liver cirrhosis,and even hepatocellular carcinoma.Therefore,antiviral therapy for CHB patients with normal ALT has always been a hot topic of clinical research.This article elaborates on the association between ALT and liver inflammation in CHB patients and the timing of antiviral therapy for CHB patients with normal ALT.
作者 丁洋 窦晓光 DING Yang, DOU Xiaoguang(Department of Infections Diseases, Shengjing Hospital of China Medical University, Shenyang 110022, China)
出处 《临床肝胆病杂志》 CAS 北大核心 2018年第5期926-929,共4页 Chinese Journal of Clinical Hepatology
基金 十三五国家传染病防治科技重大专项,辽宁省地方专业性技术创新平台建设项目,辽宁省自然科学基金项目
关键词 肝炎 乙型 慢性 丙氨酸转氨酶 临床方案 hepatitis B chronic alanine transaminase clinical protocols
作者简介 丁洋(1976-),女,副教授,博士,主要从事病毒性肝炎的基础与临床研究。;通信作者:窦晓光,电子信箱:guang40@163.com。
  • 相关文献

参考文献5

二级参考文献216

  • 1赵登蕴,覃亚勤,唐杏明,刘贵章,郑伟,农恒荣,宋家骏,谢秋燕.194例慢性乙型肝炎病理及其与血清HBV DNA、HBeAg、ALT关系的研究[J].中华实验和临床病毒学杂志,2007,21(1):35-37. 被引量:14
  • 2European Association for the Study of Liver. EASL clinical practicalguidelines:management of chronic hepatitis B virus infection[J]. JHepatol012,57(2):39920. 被引量:1
  • 3Chang IT. APASL 2012 HBV Guideline[S]. Hepatology Int012. 被引量:1
  • 4LokAS, McMahon BJ. Chronic hepatitis B: update 2009[J].Hqiatology,2009,50(3):661-662. 被引量:1
  • 5Fung J, Lai CL, Cheng C, et al. Mild-to-moderate elevation ofalanine aminotransferase increases liver stiffness measurement bytransient elastography in patients with chronic hepatitis B[J]. AmJ Gastroenterol,2011,106(3):492-496. 被引量:1
  • 6Alam S, Ahmad N, Mustafa G, et al. Evaluation of normal or minimallyelevated alanine transaminase, age and DNA level in predicting liverhistological changes in chronic hepatitis B[J]. Liver Int,2011,31(6):824-830. 被引量:1
  • 7Gobel T, Erhardt A, Herwig M, Poremba C, et al. High prevalence ofsignificant liver fibrosis and cirrfiosis in chronic hepatitis B patients withnornial ALT in central Europe. J Med VirolJOl 1,83(6):968-973. 被引量:1
  • 8Chen CJ, Yang HI, Iloeje UH, et al. Hepatitis B virus DNA levels andoutcomes in chronic hepatitis B[J]. Hepatology,2009,49(5):S72-S84. 被引量:1
  • 9Seto WK, Lai CL, Ip PPC, et al. A large population histology studyshowing the lack of association between ALT elevation and significantfibrosis in chronic hepatitis B[J], PLoS OneO 12,7(2):e32622:1 -7. 被引量:1
  • 10ZOULIM F, PERRILLO R. Hepatitis B: reflection on the cur- rent approach to antiviral therapy [ J]. J Hepatol, 2008, 48 (Suppl 1 ) : s2 -s19. 被引量:1

共引文献556

同被引文献10

引证文献1

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈